https://www.healthlawasia.com/regulations/measures-for-cyberspace-security-supervision-and-inspection-by-public-security-organs/ 2026-09-17T16:05:42+00:00 https://www.healthlawasia.com/regulations/regarding-the-provision-of-information-for-the-proper-use-of-over-the-counter-drugs-and-other-medicinal-products-and-the-implementation-of-adverse-reaction-reporting-for-suspected-cases-of-dependence/ 2026-09-17T16:03:26+00:00 https://www.healthlawasia.com/regulations/notice-of-the-general-affairs-department-of-the-national-data-administration-onissuing-the-guidelines-for-data-property-rights-registration-trial/ 2026-09-17T16:02:03+00:00 https://www.healthlawasia.com/regulations/medical-security-law-of-the-peoples-republic-of-china/ 2026-09-17T15:56:48+00:00 https://www.healthlawasia.com/regulations/announcement-for-market-regulation-on-rewards-for-internal-informants-reporting-issues-concerning-the-quality-and-safety-of-medicinal-products-and-medical-devices-2025/ 2026-09-17T12:03:03+00:00 https://www.healthlawasia.com/regulations/announcement-of-the-national-medical-products-administration-on-issuing-the-good-clinical-practice-for-drug-trials-2026/ 2026-09-14T15:15:54+00:00 https://www.healthlawasia.com/regulations/regulatory-guidance-on-gcp-compliance-inspection-framework-singapore-2026/ 2026-07-23T06:40:31+00:00 https://www.healthlawasia.com/regulations/notice-of-the-general-office-of-the-national-health-commission-on-strengthening-the-administration-of-continuous-medication-for-residents-2026/ 2026-07-23T04:13:56+00:00 https://www.healthlawasia.com/regulations/notice-of-the-general-office-of-the-national-health-commission-on-launching-the-action-plan-for-promoting-rational-medication-use-among-older-adults-2026-2030/ 2026-07-22T04:44:52+00:00 https://www.healthlawasia.com/regulations/notice-of-the-state-council-on-issuing-the-national-health-plan-for-the-15th-five-year-plan-period-2026/ 2026-07-19T23:32:35+00:00 https://www.healthlawasia.com/regulations/technical-guideline-on-the-scope-and-classification-of-gene-therapy-medicinal-products-2026-edition/ 2026-07-17T05:23:54+00:00 https://www.healthlawasia.com/regulations/notification-of-the-procedures-for-submission-of-applications-and-gdp-inspection-for-the-year-2026-thailand-2025/ 2026-07-09T01:43:10+00:00 https://www.healthlawasia.com/regulations/announcement-of-the-12th-national-centralized-volume-based-procurement-of-pharmaceuticals-2026/ 2026-07-08T05:48:34+00:00 https://www.healthlawasia.com/regulations/announcement-of-the-national-medical-products-administration-on-matters-concerning-the-application-of-the-priority-review-and-approval-procedures-for-drug-marketing-authorization-of-chemical-active-ph/ 2026-07-08T02:23:26+00:00 https://www.healthlawasia.com/regulations/interpretation-of-announcement-on-2026-medical-insurance-drug-catalog-preliminary-review-results/ 2026-07-06T03:21:53+00:00 https://www.healthlawasia.com/regulations/procedures-for-the-review-and-approval-of-applications-for-conditional-marketing-authorization-of-pharmaceutical-products-2026/ 2026-06-26T05:58:13+00:00 https://www.healthlawasia.com/regulations/guiding-principles-for-the-development-of-appropriate-pharmaceutical-packaging-specifications-2026/ 2026-06-25T01:36:38+00:00 https://www.healthlawasia.com/regulations/guiding-opinions-of-the-general-office-of-the-state-council-on-strengthening-supervision-preventing-risks-and-promoting-the-high-quality-development-of-private-investment-funds-2026/ 2026-06-17T06:25:14+00:00 https://www.healthlawasia.com/regulations/notice-of-the-general-affairs-department-of-the-national-medical-products-administration-on-ensuring-the-proper-implementation-of-work-related-to-the-segmented-manufacturing-of-biological-products-20/ 2026-06-10T01:54:12+00:00 https://www.healthlawasia.com/regulations/notice-of-the-general-office-of-the-national-medical-products-administration-on-issuing-the-compliance-guidelines-for-the-online-retail-sale-of-prescription-drugs-2026/ 2026-06-05T06:20:33+00:00 https://www.healthlawasia.com/regulations/implementation-measures-for-drug-trial-data-protection-2026/ 2026-05-27T07:35:10+00:00 https://www.healthlawasia.com/regulations/policy-on-the-handling-of-pharmaceutical-patents-in-relation-to-the-approval-review-under-the-pharmaceuticals-and-medical-devices-act-and-the-national-health-insurance-price-listing-of-medical-use-gen/ 2026-05-25T06:05:26+00:00 https://www.healthlawasia.com/regulations/measures-for-the-administration-of-medical-representatives-2026/ 2026-05-21T04:28:14+00:00 https://www.healthlawasia.com/regulations/the-supreme-peoples-procuratorate-releases-six-typical-cases-on-deepening-the-public-interest-litigation-for-food-and-drug-safety-procuratorial-supervision/ 2026-05-04T04:45:23+00:00 https://www.healthlawasia.com/regulations/regulations-regarding-clinical-drug-vietnam-2025/ 2026-05-02T02:14:35+00:00 https://www.healthlawasia.com/regulations/announcement-of-the-national-medical-products-administration-on-strengthening-the-supervision-and-administration-of-entrusted-drug-manufacturing-2025/ 2026-04-29T07:01:32+00:00 https://www.healthlawasia.com/regulations/several-opinions-of-the-general-office-of-the-state-council-on-improving-the-drug-price-formation-mechanism-2026/ 2026-04-27T05:06:19+00:00 https://www.healthlawasia.com/regulations/guiding-opinions-on-the-standardized-development-of-modern-pharmaceutical-logistics-2026/ 2026-04-23T07:24:35+00:00 https://www.healthlawasia.com/regulations/regulations-for-work-procedures-and-technical-requirements-for-drug-registration-testing-2025-revision/ 2026-04-21T04:58:21+00:00 https://www.healthlawasia.com/regulations/implementation-opinions-of-the-national-medical-products-administration-on-promoting-the-integration-of-artificial-intelligence-into-drug-regulation-2026/ 2026-04-15T07:44:31+00:00 https://www.healthlawasia.com/regulations/primary-evaluation-begins-phased-implementation-and-applications-of-new-drugs-for-registration-accepted-under-initial-phase-hong-kong-2026/ 2026-04-09T02:17:03+00:00 https://www.healthlawasia.com/regulations/anti-monopoly-law-of-the-peoples-republic-of-china-2022-amendment/ 2026-04-03T06:16:25+00:00 https://www.healthlawasia.com/regulations/announcement-of-nmpa-on-further-optimizing-the-review-and-approval-of-clinically-urgently-needed-overseas-marketed-drugs-2026/ 2026-04-01T07:27:16+00:00 https://www.healthlawasia.com/regulations/comprehensive-lifecycle-collaboration-plan-for-the-promotion-of-pharmaceutical-and-biotechnology-ventures-south-korea-2026/ 2026-03-30T02:23:42+00:00 https://www.healthlawasia.com/regulations/cybersecurity-law-of-the-peoples-republic-of-china-2025-amendment/ 2026-03-09T03:36:44+00:00 https://www.healthlawasia.com/regulations/foreign-trade-law-of-the-peoples-republic-of-china-2025-revision/ 2026-02-25T08:25:15+00:00 https://www.healthlawasia.com/regulations/circular-on-prescribing-marketing-authorization-of-drugs-and-medicinal-materials-vietnam-2025/ 2026-01-23T07:38:47+00:00 https://www.healthlawasia.com/regulations/labor-law-of-the-peoples-republic-of-china-2018-amendment/ 2026-01-19T07:33:29+00:00 https://www.healthlawasia.com/regulations/procedures-for-handling-filing-based-post-approval-changes-for-drugs-manufactured-outside-china-2026/ 2026-01-16T03:22:14+00:00 https://www.healthlawasia.com/regulations/measures-for-the-supervision-of-drug-quality-sampling-and-testing-draft-for-public-comment/ 2026-01-14T02:28:18+00:00 https://www.healthlawasia.com/regulations/trademark-law-of-the-peoples-republic-of-china-2019-amendment/ 2026-01-08T08:37:38+00:00 https://www.healthlawasia.com/regulations/regulations-on-inspection-of-exported-drugs-and-management-of-export-certificates-for-pharmaceutical-manufacturers-2025/ 2025-12-15T05:55:51+00:00 https://www.healthlawasia.com/regulations/notice-of-the-shanghai-municipal-medical-products-administration-on-issuing-the-guiding-opinions-on-modern-drug-logistics-in-shanghai/ 2025-11-27T03:35:59+00:00 https://www.healthlawasia.com/regulations/draft-for-opinions-on-regulations-on-the-quality-management-of-drug-clinical-trials-2025/ 2025-11-25T03:25:02+00:00 https://www.healthlawasia.com/regulations/case-of-an-antimonopoly-administrative-penalty-involving-a-horizontal-monopolistic-agreement-on-the-api-camphor-2025/ 2025-11-18T03:10:25+00:00 https://www.healthlawasia.com/regulations/notice-on-issuing-the-key-tasks-for-correcting-unhealthy-practices-in-the-field-of-pharmaceutical-procurement-and-medical-services-in-2025/ 2025-11-17T07:06:36+00:00 https://www.healthlawasia.com/regulations/early-consideration-on-handling-of-japanese-data-for-confirmation-of-comparability-of-biosimilars-to-the-original-biopharmaceuticals-2025/ 2025-11-12T07:20:18+00:00 https://www.healthlawasia.com/regulations/notice-by-the-general-office-of-the-state-council-regarding-implementing-the-standards-for-domestic-products-and-relevant-policies-in-government-procurement-2025/ 2025-11-12T03:07:48+00:00 https://www.healthlawasia.com/regulations/regulations-on-the-administration-of-clinical-research-and-clinical-translational-application-of-new-biomedical-technologies-2025/ 2025-11-10T05:48:44+00:00 https://www.healthlawasia.com/regulations/foreign-investment-law-of-the-peoples-republic-of-china-2019/ 2025-11-06T06:06:01+00:00 https://www.healthlawasia.com/regulations/patent-law-of-the-peoples-republic-of-china-2020-amendment/ 2025-10-31T08:01:42+00:00 https://www.healthlawasia.com/regulations/customs-law-of-the-peoples-republic-of-china-2021-amendment/ 2025-10-21T06:26:49+00:00 https://www.healthlawasia.com/regulations/administrative-measures-for-the-import-of-drugs-2012-amendment/ 2025-10-15T07:45:48+00:00 https://www.healthlawasia.com/regulations/personal-information-protection-law-of-the-peoples-republic-of-china-2021/ 2025-10-11T02:46:15+00:00 https://www.healthlawasia.com/regulations/rules-for-the-classification-of-medical-devices-2015/ 2025-10-09T06:53:15+00:00 https://www.healthlawasia.com/regulations/company-law-of-the-peoples-republic-of-china-2023/ 2025-10-09T06:50:49+00:00 https://www.healthlawasia.com/regulations/regarding-the-study-and-research-on-drugs-for-the-purpose-of-providing-information-to-support-drug-registration-and-approval-thailand-2025/ 2025-10-09T06:47:29+00:00 https://www.healthlawasia.com/regulations/innovation-in-ai-based-medical-technologies-for-national-health-improvement-south-korea-2024/ 2025-10-09T06:44:48+00:00 https://www.healthlawasia.com/regulations/the-department-of-health-establishes-preparatory-office-for-hong-kong-centre-for-medical-products-regulation-2024/ 2025-10-09T06:39:35+00:00 https://www.healthlawasia.com/regulations/anti-monopoly-guidelines-for-the-pharmaceutical-sector-by-the-state-council-anti-monopoly-and-anti-unfair-competition-commission-2025/ 2025-10-09T06:36:32+00:00 https://www.healthlawasia.com/regulations/basic-principles-concerning-japanese-data-in-cases-where-confirmatory-clinical-trials-for-pharmaceuticals-used-in-rare-diseases-have-been-conducted-exclusively-outside-japan-2024/ 2025-10-09T06:27:23+00:00 https://www.healthlawasia.com/regulations/data-security-law-of-the-peoples-republic-of-china-2021/ 2025-10-09T06:24:41+00:00 https://www.healthlawasia.com/regulations/technical-review-guidelines-for-cybersecurity-of-medical-devices-second-edition-2020/ 2025-10-09T06:07:40+00:00 https://www.healthlawasia.com/regulations/the-general-office-of-the-state-councils-opinions-on-deepening-the-reform-of-drug-and-medical-device-regulation-and-promoting-the-high-quality-development-of-the-pharmaceutical-industry-2024/ 2025-10-09T05:57:14+00:00 https://www.healthlawasia.com/regulations/notice-by-the-china-national-medical-products-administration-of-issuing-the-pilot-work-plan-for-optimizing-the-review-and-approval-of-clinical-trials-of-innovative-drugs-2024/ 2025-10-09T05:51:04+00:00 https://www.healthlawasia.com/regulations/notice-on-issuing-the-pilot-work-plan-for-expanding-in-the-field-of-wholly-foreign-owned-hospitals-2024/ 2025-09-19T07:04:12+00:00 https://www.healthlawasia.com/regulations/the-general-office-of-the-state-councils-notice-on-printing-and-distributing-the-key-tasks-for-deepening-the-reform-of-the-medical-and-health-system-in-2024/ 2025-09-19T01:09:18+00:00 https://www.healthlawasia.com/regulations/notice-by-the-national-healthcare-security-administration-and-the-national-health-commission-on-improving-the-mechanism-for-centralized-pharmaceutical-procurement-and-its-implementation-2024/ 2025-09-18T04:45:02+00:00 https://www.healthlawasia.com/regulations/announcement-of-the-center-for-medical-device-evaluation-of-the-national-medical-products-administration-on-matters-concerning-further-enhancing-support-for-innovative-medical-devices-2025/ 2025-09-18T02:18:35+00:00 https://www.healthlawasia.com/regulations/announcement-of-the-national-medical-products-administration-and-the-national-intellectual-property-administration-on-issuing-the-implementation-measures-for-the-mechanism-for-early-settlement-of-drug/ 2025-09-18T02:04:00+00:00 https://www.healthlawasia.com/regulations/announcement-of-the-national-medical-products-administration-on-issuing-the-measures-for-the-administration-of-medicinal-product-recalls-2022/ 2025-09-17T05:19:13+00:00 https://www.healthlawasia.com/regulations/national-medical-products-administration-releases-the-2024-annual-report-on-national-cosmetic-sampling-inspection-2025/ 2025-09-17T04:38:46+00:00 https://www.healthlawasia.com/regulations/announcement-on-further-adjustments-and-optimizations-for-the-production-of-imported-medical-device-products-by-domestic-enterprises-in-china-2025/ 2025-09-17T02:40:49+00:00 https://www.healthlawasia.com/regulations/announcement-by-the-state-administration-for-market-regulation-on-the-publication-of-the-compliance-guidelines-for-pharmaceutical-companies-to-prevent-commercial-bribery-risks-2025/ 2025-09-17T02:16:52+00:00 https://www.healthlawasia.com/regulations/measures-for-the-administration-of-the-registration-and-recordation-of-cosmetics-2021/ 2025-09-16T05:08:33+00:00 https://www.healthlawasia.com/regulations/measures-for-the-administration-of-inspection-and-supervision-of-the-imported-medical-instruments-2007/ 2025-09-16T04:30:09+00:00 https://www.healthlawasia.com/regulations/notice-of-the-national-medical-insurance-administration-and-the-national-health-commission-on-issuing-several-measures-to-support-the-high-quality-development-of-innovative-drugs-2025/ 2025-09-16T02:30:06+00:00 https://www.healthlawasia.com/regulations/announcement-of-the-national-medical-products-administration-regarding-matters-related-to-the-importation-of-commercial-scale-batches-of-drugs-already-marketed-abroad-prior-to-approval-in-china-2025/ 2025-09-16T02:02:37+00:00 https://www.healthlawasia.com/regulations/guidance-on-therapeutic-product-registration-in-singapore-2025/ 2025-09-16T01:01:17+00:00 https://www.healthlawasia.com/regulations/announcement-of-the-national-medical-products-administration-on-further-enhancing-the-issuance-of-drug-manufacturing-licenses-2025/ 2025-09-15T06:57:13+00:00 https://www.healthlawasia.com/regulations/measures-for-the-supervision-and-administration-of-production-and-distribution-of-cosmetics-2021/ 2025-09-15T04:01:50+00:00 https://www.healthlawasia.com/regulations/measures-for-the-administration-of-registration-and-recordation-of-medical-devices-2021/ 2025-09-15T02:20:20+00:00 https://www.healthlawasia.com/regulations/measures-for-the-drug-administration-registration-2020/ 2025-09-15T01:21:11+00:00 https://www.healthlawasia.com/regulations/regulation-on-the-supervision-and-administration-of-cosmetics-2020/ 2025-09-12T06:48:36+00:00 https://www.healthlawasia.com/regulations/regulations-for-the-implementation-of-the-drug-administration-law-of-the-peoples-republic-of-china-2024-revision/ 2025-09-12T04:50:43+00:00 https://www.healthlawasia.com/regulations/drug-administration-law-of-the-peoples-republic-of-china-2019-revision/ 2025-09-12T04:28:20+00:00 https://www.healthlawasia.com/regulations/measures-for-the-supervision-and-administration-of-medical-device-production-2022/ 2025-09-12T02:13:46+00:00 https://www.healthlawasia.com/regulations/provisions-for-the-administration-of-cosmetic-registration-and-recordation-2021/ 2025-09-12T01:10:27+00:00 https://www.healthlawasia.com/regulations/administrative-provisions-on-instructions-for-use-and-labels-of-medical-devices-2014/ 2025-09-11T06:45:26+00:00 https://www.healthlawasia.com/regulations/product-quality-law-of-the-peoples-republic-of-china-2018-amendment/ 2025-09-11T02:45:07+00:00 https://www.healthlawasia.com/regulations/provisional-regulation-on-the-administration-of-designated-domestic-responsible-person-by-overseas-drug-marketing-authorization-holders-2024/ 2025-09-11T02:03:35+00:00 https://www.healthlawasia.com/regulations/regulations-on-the-supervision-and-administration-of-medical-devices-2024-revision/ 2025-09-11T01:31:55+00:00